Lenalidomide therapy for primary myelodysplastic syndromes with isolated del(5q): Determinants of response and survival in a real-world setting

Amritpal Singh, Aref Al-Kali, James M. Foran, Michelle A. Elliott, Kebede Begna, Talha Badar, Nandita Khera, Farah Fleti, Maymona Abdelmagid, Kareen K. Reichard, Rhett P. Ketterling, Animesh Pardanani, Naseema Gangat, Ayalew Tefferi

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)E377-E379
JournalAmerican journal of hematology
Issue number10
StatePublished - Oct 2022

ASJC Scopus subject areas

  • Hematology

Cite this